Dr. Aaron Cravens is founder and CEO of Revel Pharmaceuticals. The company opens an entirely new field in the treatment of age-related molecular damage – breaking cross-linked collagen fibers and repairing damage that accumulates as we age. Prior to Revel, Dr. Cravens was at Google X and worked as a consultant for several San Francisco biotechnology companies. He was previously the founder of a skincare startup and trained at Stanford’s IGNITE Business School Program. Aaron has a BS in Mathematics from the University of Rochester and a PhD in Bioengineering from Stanford University, advised by Dr. Christina Smolke.
